2018
DOI: 10.1016/j.mito.2017.08.012
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial DNA haplogroup K as a contributor to protection against thyroid cancer in a population from southeast Europe

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
13
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 58 publications
2
13
0
Order By: Relevance
“…To our knowledge this report is the first to use survival and cause-specific mortality data in multigeneration matrilineages to identify mitochondrial genetic variants that may slow aging and contribute to longevity by lowering the risk of not just one, but several common causes of death. The previously reported published case-control studies [1][2][3][4][5][6][7][8] attributing protection from several aging-related diseases to haplogroup K, combined with the evidence presented here of haplogroup K2's broad health benefits, based on morbidity and mortality data from multiple multigeneration matrilineages, strongly support the conclusion that haplogroup K, and especially the K2 subclade, contributes to better survival by reducing the risk of dying from not just one, but multiple common diseases. How haplogroup K2 accomplishes this has yet to be determined, and may involve multiple mechanisms.…”
Section: Discussionsupporting
confidence: 79%
See 1 more Smart Citation
“…To our knowledge this report is the first to use survival and cause-specific mortality data in multigeneration matrilineages to identify mitochondrial genetic variants that may slow aging and contribute to longevity by lowering the risk of not just one, but several common causes of death. The previously reported published case-control studies [1][2][3][4][5][6][7][8] attributing protection from several aging-related diseases to haplogroup K, combined with the evidence presented here of haplogroup K2's broad health benefits, based on morbidity and mortality data from multiple multigeneration matrilineages, strongly support the conclusion that haplogroup K, and especially the K2 subclade, contributes to better survival by reducing the risk of dying from not just one, but multiple common diseases. How haplogroup K2 accomplishes this has yet to be determined, and may involve multiple mechanisms.…”
Section: Discussionsupporting
confidence: 79%
“…Mitochondrial haplogroup K has been reported to be increased in frequency in exceptionally long-lived individuals as compared to younger controls, in French [1], Irish [2], and Finnish [3] populations. Other studies, also with a case-control design, have reported an association of haplogroup K with decreased risk of Parkinson Disease [4], Alzheimer Disease in APOE 4 allele carriers [5], pancreatic cancer [6], thyroid cancer [7], and both transient ischemic attack and ischemic stroke [8].…”
Section: Introductionmentioning
confidence: 99%
“…But, some of the findings are still debatable. Moreover, several studies reported that mtDNA polymorphisms and mitochondrial haplogroups have either predisposing or protective role in various cancer types (Cocos et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…However, thyroid cancer is the most common endocrine malignancy covers 90% of the all endocrine malignancies and it has rapidly increase in global incidence in recent decades (Cocos et al, 2017;Xing, 2013). Beside this, thyroid carcinoma was the third most common malignancy in both gender (12%) in Turkey and the second most common malignancy among Turkish women (12%) according to the 2017 Turkish health ministry official cancer report (http://kanser.gov.tr) .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation